Literature DB >> 24373790

Successful desensitization to brentuximab vedotin after anaphylaxis.

Amy E O'Connell1, Joyce P Lee2, Christina Yee3, Jennifer Kesselheim4, Anahita Dioun3.   

Abstract

Keywords:  Anaphylaxis; Anaplastic large cell lymphoma; Brentuximab vedotin; Desensitization; Drug allergy

Mesh：

Substances：

Year:  2013        PMID： 24373790     DOI： 10.1016/j.clml.2013.11.003

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  3 in total

Review 1.  Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies.

Authors:  Rafael Bonamichi-Santos; Mariana Castells
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

2.  Desensitization of Brentuximab Vedotin in a Patient with Hodgkin Lymphoma.

Authors:  Sidra Khalid; Aariez Khalid; Bernadette A Clark; Hamed Daw
Journal:  Cureus       Date:  2018-07-13

3.  Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: a case report.

Authors:  Attilio Di Girolamo; Marcello Albanesi; Alessandro Sinisi; Eustachio Nettis; Danilo Di Bona; Maria Filomena Caiaffa; Luigi Macchia
Journal:  Clin Mol Allergy       Date:  2018-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.